Clinical advances in CD47-SIRPα axis-targeted cancer immunotherapy: Mechanisms, strategies, challenges, and future perspectives

Biochemical and Biophysical Research Communications 2026

View at publisher

Authors: Yuanyuan Li, Xiaomei He, Hongli Zhou, Hongli Zhou, Yu Tian, Qingqing Zhang, Jianyun Zhou, Jianyun Zhou

DOI: 10.1016/j.bbrc.2026.153330

Cited by: 2

References: 99

Fields of Study & Subjects

Phagocytosis and Immune Regulation Immunotherapy and Immune Responses Nanoplatforms for cancer theranostics

References 99